Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 1.6B | 1.6B | 1.6B |
Cost of revenue | 672M | 696M | 659M | 668M |
Gross profit | 841M | 896M | 923M | 939M |
Operating expense | ||||
Research & development | 96M | 130M | 111M | 116M |
Selling general and admin | 420M | 470M | 422M | 437M |
Other operating expenses | — | — | — | — |
Operating income | 325M | 296M | 390M | 386M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 124M | 132M | 126M | 131M |
Other income expense | -100M | -35M | -57M | -20M |
Pretax income | 101M | 129M | 207M | 235M |
Tax provision | 14M | 20M | -152M | 40M |
Net income | 87M | 109M | 359M | 195M |
Basic EPS | 0.3 | 0.4 | 1.4 | 0.8 |
Diluted EPS | 0.3 | 0.4 | 1.4 | 0.8 |
Basic average shares | 257.9M | 257.7M | 257.5M | 257.3M |
Diluted average shares | 261.0M | 259.9M | 259.8M | 258.6M |
EBITDA | 397M | 361M | 459M | 446M |
Net income from continuing op. | 87M | 109M | 359M | 195M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |